Ibex Wealth Advisors Sells 183,825 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Ibex Wealth Advisors trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 97.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,961 shares of the company’s stock after selling 183,825 shares during the quarter. Ibex Wealth Advisors’ holdings in GE HealthCare Technologies were worth $310,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Cherry Creek Investment Advisors Inc. boosted its position in GE HealthCare Technologies by 0.3% in the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock valued at $2,920,000 after buying an additional 114 shares during the period. Quent Capital LLC boosted its holdings in shares of GE HealthCare Technologies by 18.4% in the third quarter. Quent Capital LLC now owns 766 shares of the company’s stock valued at $72,000 after purchasing an additional 119 shares during the period. Greenleaf Trust increased its holdings in GE HealthCare Technologies by 1.7% during the 3rd quarter. Greenleaf Trust now owns 7,619 shares of the company’s stock worth $715,000 after purchasing an additional 124 shares during the period. Westside Investment Management Inc. raised its position in GE HealthCare Technologies by 32.0% during the 3rd quarter. Westside Investment Management Inc. now owns 516 shares of the company’s stock valued at $48,000 after purchasing an additional 125 shares in the last quarter. Finally, Quarry LP lifted its holdings in shares of GE HealthCare Technologies by 28.3% in the 2nd quarter. Quarry LP now owns 594 shares of the company’s stock worth $46,000 after buying an additional 131 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

GEHC has been the topic of several research reports. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $96.00.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Stock Performance

GEHC opened at $87.85 on Thursday. The company has a market cap of $40.14 billion, a P/E ratio of 24.13, a price-to-earnings-growth ratio of 2.88 and a beta of 1.11. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm’s 50-day moving average price is $82.61 and its 200-day moving average price is $84.92. GE HealthCare Technologies Inc. has a 52-week low of $72.52 and a 52-week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same quarter in the prior year, the business posted $0.99 EPS. GE HealthCare Technologies’s revenue for the quarter was up .9% compared to the same quarter last year. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.